 
Congress
Sponsors
 Search
Write
About
màj
: 22/07/98
|
Bibliographie
1. Bousquet J, Chanez
P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge
P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB.
Eosinophilic inflammation in asthma. N Engl J Med 1990;
323: 1033-9.
2. De Blic J, Dhuont
P, Scheinmann P, Pfister A, Paupe J, Da Lage C. Interet
diagnostique de l'eosinophilie des sécrétions
bronchiques de l'enfant. La nouvelle presse médicale
1980; 9: 3627.
3. Gibson PG,
Girgis-Gabardo A, Morris MM, Mattoli S, Kay JM, Dolovich
J, Denburg J, Hargreave FE. Cellular characteristics of
sputum from patients with asthma and chronic bronchitis.
Thorax 1989; 44: 693-9.
4. Bickerman HA,
Sproul EE, Barach AL. An aerosol method of producing
bronchial secretions in human subjects: a clinical
technic for the detection of lung cancer. Dis. Chest
1958; 33: 347-62.
5. Pitchenik AE,
Ganjei P, Torres A, Evans DA, Rubin E, Baier H. Sputum
examination for the diagnosis of pneumocystis carinii
pneumonia in the acquired immunodeficiency syndrome. Am.
Rev. Respir. Dis. 1986; 133: 226-9.
6. Chouaid C, Housset
B, Poirot JL, Roux P, Lebeau B. Cost effectiveness of the
uinduced sputum technique for the diagnosis of
pneumocystis carinii pneumonia in HIV-induced patients.
Eur. Respir. J. 1993; 6: 248-52.
7. Pin I, Gibson PG,
Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave
FE, Dolovich J. Use of induced sputum cell counts to
investigate airway inflammation in asthma. Thorax 1992;
47: 25-9.
8. Fahy JV, Steiger
DJ, Liu J, Basbaum CB, Finkbeiner WE, Boushey HA. Markers
of mucus secretion and DNA levels in induced sputum from
asthmatic and from healthy subjects. Am Rev Respir Dis
1993; 147: 1132-7.
|
9.. Fahy JV, Liu J, Wong H, Boushey HA.
Cellular and biochemical analysis of induced sputum from
asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147:
1126-31.
10. Sheppard D, Rizk NW, Boushey HA,
Bethel RA. Mechanism of cough and bronchoconstriction induced by
distilled water aerosol. Am Rev Respir Dis 1983; 127: 691-4.
11.. Eschenbacher WL, Boushey HA, Sheppard
D. Alteration in osmolarity of inhaled aerosols cause
bronchoconstriction and cough, but absence of a permeant anion
causes cough alone. Am Rev Respir Dis 1984; 129: 211-5.
12.. Pavia D, Thomson ML, Clarke SW.
Enhanced clearance of secretions from the human lung after the
administration of hypertonic saline aerosol. Am. Rev. Respir.
Dis. 1978; 117: 199-203.
13.. Robinson M, King M, Tomkiewskz RP,
Regnis JA, Bailey DL, Peat J, Bye PTP. Effect of hypertonic
saline, amiloride and cough on mucociliary clearance in patients
with cystic fibrosis. Am. J. Respir. Crit. Care Med. 1994; 149:
A669.
14.. Umeno E, McDonald D, Nadel JA.
Hypertonic saline increases vascular permeability in the rat by
producing neurogenic inflammation. J. Clin. Invest. 1990; 85:
1905-8.
15.. Jongejan RC, De-Jongste JC, Raatgeep
RC, Bonta IL, Kerrebijn KF. Effects of changes in osmolarity on
isolated human airways. J Appl Physiol 1990; 68: 1568-75.
16.. Eggleston PA, Kagey-Sobotka A,
Lichtenstein LM. A comparison of the osmotic activation of
basophils and human lung mast cells. Am Rev Respir Dis 1987; 135:
1043-8.
17.. Popov TA, Pizzichini E, Kolendowicz
R, Punthakee Z, Dolovich J, Hargreave FE. Some technical factors
influencing the induction of sputum for cell analysis. Eur.
Respir. J. 1995; 8: 559-65.
18.. Pin I, Freitag AP, O'Byrne PM,
Girgis-Gabardo A, Watson RM, Dolovich J, Denburg JA, Hargreave
FE. Changes in the cellular profile of induced sputum after
allergen-induced asthmatic responses. Am Rev Respir Dis 1992;
145: 1265-9.
19.. Pizzichini MMM, Popov TA, Efthimiadis
A, Hussack P, Evans S, Pizzichini E, Dolovich J, Hargreave FE.
Spontaneous and induced sputum to measure indices of airway
inflammation in asthma. Amer J Respir Crit Care Med 1996; 154:
866-869.
20.. Gershman NH, Wong HH, Liu JT,
Mahlmeister MJ, Fahy JV. Comparison of two methods of collecting
induced sputum in asthmatic subjects. Eur Resp J 1996; 9:
2448-2453.
21.. Pizzichini E, Pizzichini MMM,
Efthimiadis A, Hargreave FE, Dolovich J. Measurement of
inflammatory indices in induced sputum: effects of selection of
sputum to minimize salivary contamination. Eur. Respir. J. 1996;
9: 1174-80.
22.. Virchow J Jr., Holscher U, Virchow C
Sr. Sputum ECP levels correlate with parameters of airflow
obstruction. Am Rev Respir Dis 1992; 146: 604-6.
23.. Tockman MS, Qiao Y, Li L, Zhao G,
Sharma R, Cavenaugh LL, Erozan Y. Safe separation of sputum cells
from mucoid glycoprotein. Acta Cytologica 1995; 39: 1128-36.
24.. Efthimiadis A, Pizzichini MMM,
Pizzichini E, Dolovich J, Hargreave FE. Induced sputum cell and
fluid-phase indices of inflammation: Comparison of treatment with
dithiothreitol vs phosphate-buffered saline. Eur Resp J 1997; 10:
1336-1340.
25.. Efthimiadis A, Popov T, Kolendowicz
R, Dolovich J, Hargreave FE. Increasing the yield of sputum cells
for examination. Am. J. Respir. Crit. Care Med. 1994; : A949.
26.. Smith CM, Anderson SD. Inhalational
challenge using hypertonic saline in asthmatic subjects: a
comparison with responses to hyperpnoea, methacholine and water.
Eur Respir J 1990; 3: 144-51.
27.. Smith CM, Anderson SD. Inhalation
provocation tests using nonisotonic aerosols. J. Allergy Clin.
Immunol. 1989; 84: 781-90.
28.. Belcher NG, Lee TH, Rees PJ. Airway
responses to hypertonic saline, exercise and histamine challenges
in bronchial asthma. Eur Respir J 1989; 2: 44-8.
29.. Boulet LP, Legris C, Thibault L,
Turcotte H. Comparative bronchial responses to hyperosmolar
saline and methacholine in asthma. Thorax 1987; 42: 953-8.
30.. Twaddell SH, Gibson PG, Carty KL,
Henry RL. Assessment of airway inflammation in children with
acute asthma using induced sputum. Eur. Respir. J. 1996; 9:
2104-8.
31.. Louis R, Shute J, Biagi S, Stanciu L,
Marrelli F, Tenor H, Hidi R, Djukanovic R. Cell infiltration,
ICAM-1 expression, and eosinophil chemotactic activity in
asthmatic sputum. Amer J Respir Crit Care Med 1997; 155: 466-472.
32.. Maestrelli P, Calcagni PG, Saetta M,
Di-Stefano A, Hosselet JJ, Santonastaso A, Fabbri LM, Mapp CE.
Sputum eosinophilia after asthmatic responses induced by
isocyanates in sensitized subjects. Clin Exp Allergy 1994; 24:
29-34.
33.. Bacci E, Cianchetti S, Paggiaro PL,
Carnevali S, Bancalari L, Dente FL, DiFranco A, Giannini D,
Vagaggini B, Giuntini C. Comparison between hypertonic and
isotonic saline-induced sputum in the evaluation of airway
inflammation in subjects with moderate asthma. Clin Experiment
Allergy 1996; 26: 1395-1400.
34.. Keatings VM, Collins PD, Scott DM,
Barnes PJ. Differences in interleukin-8 and tumor necrosis
factor-a in induced sputum from patients with chronic obstructive
pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 1996;
153: 530-4.
35.. Iredale MJ, Wanklyn SA, Phillips IP,
Krausz T, Ind PW. Non-invasive assessment of bronchial
inflammation in asthma: no correlation between eosinophilia of
induced sputum and bronchial responsiveness to inhaled hypertonic
saline. Clin Exp Allergy 1994; 24: 940-5.
36.. Pizzichini MMM, Pizzichini E,
Clelland L, Efthimiadis A, Mahony J, Dolovich J, Hargreave FE.
Sputum in severe exacerbations of asthma. Am. J. Respir. Crit.
Care Med. 1997; 155: 1501-8.
37.. Wong HH, Fahy JV. Safety of one
method of sputum induction in asthmatic subjects. Am. J. Respir.
Crit. Care Med. 1997; 156: 299-303.
38.. 1995. Global strategy for asthma
management and prevention. WHO/NHLBI workshop report. National
institutes of Health, National Heart, Lung and Blood Institute,
Publication Number 95-3659.
39.. Veen JCCMI, deGouw HWFM, Smits HH,
Sont JK, Hiemstra PS, Sterk PJ, Bei EH. Repeatability of cellular
and soluble markers of inflammation in induced sputum from
patients with asthma. Eur Resp J 1996; 9: 2441-2447.
40.. Pizzichini E, Pizzichini MMM,
Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ,
Dolovich J, Hargreave FE. Indices of airway inflammation in
induced sputum: reproductibility and validity of cell and
fluid-phase measurements. Am. J. Respir. Crit. Care Med. 1996;
154: 308-17.
41.. Kidney JC, Wong AG, Efthimiadis A,
Morris MM, Sears MR, Dolovich J, Hargreave FE. Elevated B cells
in sputum of asthmatics. Am. J. Respir. Crit. Care Med. 1996;
153: 540-4.
42.. Virchow J Jr., Kroegel C, Hage U,
Kortsik C, Matthys H, Werner P. Comparison of sputum-ECP levels
in bronchial asthma and chronic bronchitis. Allergy 1993; 48:
112-8.
43.. Claman DM, Boushey HA, Liu J, Wong H,
Fahy JV. Analysis of induced sputum to examine the effects of
prednisone on airway inflammation in asthmatic subjects. J
Allergy Clin Immunol 1994; 94: 861-9.
44.. Greiff L, Andersson M, Svensson C,
Alkner U, Persson CGA. Glucocorticosteroids may not inhibit
plasma exudation by direct vascular antipermeability effects in
human airways. Eur. Respir. J. 1994; 7: 1120-4.
45.. Schoonbrood DFM, Out TA, Lutter R,
Reimert CM, van Overveld FJ, Jansen HM. Plasma protein leakage
and local secretion of proteins assessed in sputum in asthma and
COPD. The effect of inhaled corticosteroids. Clinica chimica Acta
1995; 240: 163-78.
46.. Ollerenshaw SL, Woolcock AJ.
Characteristics of the inflammation in biopsies from large
airways of subjects with asthma and subjects with chronic airflow
limitation. Am Rev Respir Dis 1992; 145: 922-7.
47.. Gauvreau GM, Doctor J, Watson RM,
Jordana M, O'Byrne P. Effects of inhaled budesonide on
allergen-induced airway responses and airway inflammation. Am. J.
Respir. Crit. Care Med. 1996; 154: 1267-71.
48.. Ronchi MC, Piragino C, Rosi E,
Amendola M, Duranti R, Scano G. Role of sputum differential cell
count in detecting airway inflammation in patients with chronic
bronchial asthma or COPD. Thorax 1996; 51: 1000-1004.
49.. Keatings VM, Jatakanon A, Worsdell
YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on
inflammatory indices in asthma and COPD. Amer J Respir Crit Care
Med 1997; 155: 542-548.
50.. Keatings VM, Barnes PJ. Granulocyte
activation markers in induced sputum: Comparison between chronic
obstructive pulmonary disease, asthma, and normal subjects. Amer
J Respir Crit Care Med 1997; 155: 449-453.
51.. Lacoste JY, Bousquet J, Chanez P,
Van-Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I,
Godard P, Michel FB. Eosinophilic and neutrophilic inflammation
in asthma, chronic bronchitis, and chronic obstructive pulmonary
disease. J Allergy Clin Immunol 1993; 92: 537-48.
52.. Fahy JV, Wong H, Liu J, Boushey HA.
Comparison of samples collected by sputum induction and
bronchoscopy from asthmatic and healthy subjects. Am. J. Respir.
Crit. Care Med. 1995; 152: 53-8.
53.. Maestrelli P, Saetta M, Di Stefano A,
Calcagni PG, Turato G, Ruggieri MP, Roggeri A, Mapp CE, Fabbri
LM. Comparison of leucocyte counts in sputum, bronchial biopsies,
and bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 1995;
152: 1926-31.
54.. Grootendorst DC, Sont JK, Willems
LNA, Kluinnelemans JC, Vankrieken JHJM, Veseliccharvat M, Sterk
PJ. Comparison of inflammatory cell counts in asthma: Induced
sputum vs bronchoalveolar lavage and bronchial biopsies. Clin
Experiment Allergy 1997; 27: 769-779.
55.. Keatings VM, Evans DJ, Oconnor BJ,
Barnes PJ. Cellular profiles in asthmatic airways: A comparison
of induced sputum, bronchial washings, and bronchoalveolar lavage
fluid. Thorax 1997; 52: 372-374.
56.. Kraft M, Djukanovic R, Wilson S,
Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma.
Amer J Respir Crit Care Med 1996; 154: 1505-1510.
57.. Motojima S, Frigas E, Loegering DA,
Gleich GJ. Toxicity of eosinophil cationic proteins for guinea
pig tracheal epithelium in vitro. Am. J. Respir. Crit. Care Med.
1989; 139: 801-5.
58.. Durham SR, Loegering DA, Dunnette S,
Gleich GJ, Kay AB. Blood eosinophils and eosinophil-derived
proteins in allergic asthma. J Allergy Clin Immunol 1989; 84:
931-6.
59.. Adelroth E, Rosenhall L, Johansson
SA, Linden M, Venge P. Inflammatory cells and eosinophilic
activity in asthmatics investigated by bronchoalveolar lavage.
The effects of antiasthmatic treatment with budesonide or
terbutaline. Am Rev Respir Dis 1990; 142: 91-9.
60.. Venge P, LE LR, Olsson I.
Radioimmunoassay of human eosinophil cationic protein. Br J
Haematol 1977; 37: 331-5.
61.. Fahy JV, Liu J, Wong H, Boushey HA.
Analysis of cellular and biochemical constituents of induced
sputum after allergen challenge: a method for studying allergic
airway inflammation. J Allergy Clin Immunol 1994; 93: 1031-9.
62.. Konno S, Gonokami Y, Kurokawa M,
Asano K, Okamoto K, Adachi M. Cytokine concentrations in sputum
of asthmatic patients. Int. Arch. Allergy Immunol. 1996; 109:
73-8.
63.. Pizzichini E, Pizzichini MMM,
Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway
inflammation in asthma: Eosinophils and eosinophilic cationic
protein in induced sputum compared with peripheral blood. J
Allerg Clin Immunol 1997; 99: 539-544.
64.. Sorva R, Metso T, Turpeinen M,
Juntunen-Backman K, Bjšrksten F, Haahtela T. Eosinophil
cationic protein in induced sputum as a marker of inflammation in
asthmatic children. Pediatr. Allergy Immunol. 1997; 8: 45-50.
65.. Gelder CM, Thomas PS, Yates DH,
Adcock IM, Morrisson JFJ, Barnes PJ. Cytokine expression in
normal, atopic, and asthmatic subjects using the combination of
sputum induction and the polymerase chain reaction. Thorax 1995;
50: 1033-7.
9.66. Turner MO, Hussack P, Sears MR,
Dolovich J, Hargreave FE. Exacerbations of asthma without sputum
eosinophilia. Thorax 1995; 50: 1057-61.
67.. Pang GT, Clancy RL, Reeves GE.
Isolation and functional characterization of T cells from human
sputum. Clin. Exp. Immunol. 1995; 102: 642-8.
68.. Vagaggini B, Paggiaro PL, Giannini D,
Di Franco A, Cianchetti S, Carnevali S, Taccola M, Bacci E,
Bancalari L, Dente FL, Giuntini C. Effect of short-term NO2
exposure on induced sputum in normal, asthmatic and COPD
subjects. Eur. Respir. J. 1996; 9: 1852-7.
69.. Kurashima K, Fujimura M, Matsuda T,
Kobayashi T. Surface activity of sputum from acute asthmatic
patients. Am. J. Respir. Crit. Care Med. 1997; 155: 1254-9.
.
AsmanetCongrès Conçue et réalisée par: Michel Godard (at) Top
Date de création: August 1996- Dernière mise à jour: 22/07/98
Le secret des correspondances transmises sur le réseau Internet
n'est pas garanti.
Toute personne citée dispose d'un droit d'accès, de
modification, de rectification et de suppression des données le
concernant (art. 34 de la loi "Informatique et
Libertés"
n° 78-17 du 6 janvier 1978). Pour l'éxercer adressez-vous à Michel Godard (at)
